These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19624910)

  • 1. Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workers.
    LeDuc JW; Anderson K; Bloom ME; Carrion R; Feldmann H; Fitch JP; Geisbert JB; Geisbert TW; Holbrook MR; Jahrling PB; Ksiazek TG
    Emerg Infect Dis; 2009 Jul; 15(7):e1. PubMed ID: 19624910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory security and emergency response guidance for laboratories working with select agents. Centers for Disease Control and Prevention.
    Richmond JY; Nesby-O'Dell SL
    MMWR Recomm Rep; 2002 Dec; 51(RR-19):1-6. PubMed ID: 12515340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European perspective of 2-person rule for biosafety level 4 laboratories.
    Ippolito G; Nisii C; Di Caro A; Brown D; Gopal R; Hewson R; Lloyd G; Gunther S; Eickmann M; Mirazimi A; Koivula T; Georges Courbot MC; Raoul H; Capobianchi MR
    Emerg Infect Dis; 2009 Nov; 15(11):1858. PubMed ID: 19891889
    [No Abstract]   [Full Text] [Related]  

  • 4. Framework for leadership and training of Biosafety Level 4 laboratory workers.
    Le Duc JW; Anderson K; Bloom ME; Estep JE; Feldmann H; Geisbert JB; Geisbert TW; Hensley L; Holbrook M; Jahrling PB; Ksiazek TG; Korch G; Patterson J; Skvorak JP; Weingartl H
    Emerg Infect Dis; 2008 Nov; 14(11):1685-8. PubMed ID: 18976549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment.
    Shurtleff AC; Garza N; Lackemeyer M; Carrion R; Griffiths A; Patterson J; Edwin SS; Bavari S
    Viruses; 2012 Dec; 4(12):3932-51. PubMed ID: 23342380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BSL-3 laboratory practices in the United States: comparison of select agent and non-select agent facilities.
    Richards SL; Pompei VC; Anderson A
    Biosecur Bioterror; 2014; 12(1):1-7. PubMed ID: 24552359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biosafety and biosecurity in the medical laboratory. Update and trends].
    Ionescu G; Neguţ M; Combiescu AA
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):91-9. PubMed ID: 19326721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for Biosafety Training Programs for Workers Assigned to BSL-3 Research Laboratories.
    Homer LC; Alderman TS; Blair HA; Brocard AS; Broussard EE; Ellis RP; Frerotte J; Low EW; McCarthy TR; McCormick JM; Newton JM; Rogers FC; Schlimgen R; Stabenow JM; Stedman D; Warfield C; Ntiforo CA; Whetstone CT; Zimmerman D; Barkley E
    Biosecur Bioterror; 2013 Mar; 11(1):10-9. PubMed ID: 23477631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the role and effectiveness of institutional biosafety committees in providing oversight and security at biocontainment laboratories.
    Race MS; Hammond E
    Biosecur Bioterror; 2008 Mar; 6(1):19-35. PubMed ID: 18386970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of Biosafety Level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting.
    Mourya DT; Yadav PD; Majumdar TD; Chauhan DS; Katoch VM
    Indian J Med Res; 2014 Aug; 140(2):171-83. PubMed ID: 25297350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological research and security institutes].
    Darsie G; Falczuk AJ; Bergmann IE
    Rev Sci Tech; 2006 Apr; 25(1):321-7. PubMed ID: 16796057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosafety practices associated with potential agents of biocrime and biowarfare.
    Burnett LC
    Curr Protoc Microbiol; 2006 Dec; Chapter 1():Unit 1A.2. PubMed ID: 18770570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosafety. Biodefense watchdog project folds, leaving a void.
    Kaiser J
    Science; 2008 Feb; 319(5865):886. PubMed ID: 18276856
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of Restricted Experiment Requests, Division of Select Agents and Toxins, Centers for Disease Control and Prevention, 2006-2013.
    Smith J; Gangadharan D; Weyant R
    Health Secur; 2015; 13(5):307-16. PubMed ID: 26347984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the roles and structure of international high-security veterinary laboratories for infectious animal diseases.
    Murray PK
    Rev Sci Tech; 1998 Aug; 17(2):426-43. PubMed ID: 9713888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosafety Training and Incident-reporting Practices in the United States: A 2008 Survey of Biosafety Professionals.
    Chamberlain AT; Burnett LC; King JP; Whitney ES; Kaufman SG; Berkelman RL
    Appl Biosaf; 2009; 14(3):135-143. PubMed ID: 20890389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a personnel reliability program as a facilitator of biosafety and biosecurity culture in BSL-3 and BSL-4 laboratories.
    Higgins JJ; Weaver P; Fitch JP; Johnson B; Pearl RM
    Biosecur Bioterror; 2013 Jun; 11(2):130-7. PubMed ID: 23745523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network Experiences from a Cross-Sector Biosafety Level-3 Laboratory Collaboration: A Swedish Forum for Biopreparedness Diagnostics.
    Thelaus J; Lindberg A; Thisted Lambertz S; Byström M; Forsman M; Lindmark H; Knutsson R; Båverud V; Bråve A; Jureen P; Lundin Zumpe A; Melefors Ö
    Health Secur; 2017; 15(4):384-391. PubMed ID: 28805472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Employee Safety and Biosafety Applications in Microbiology Laboratories; A Multicenter Evaluation in Turkey].
    Köroğlu M; Altındiş S; Aydemir Ö; Yüksel B; Demiray T; Erkorkmaz Ü; Aslan FG; Otlu B; Altındiş M;
    Mikrobiyol Bul; 2020 Jul; 54(3):347-367. PubMed ID: 32755513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Departures from Regulatory Requirements Identified During Inspections Conducted by the US Federal Select Agent Program, 2014-15.
    Bjork A; Sosin DM
    Health Secur; 2017; 15(6):587-598. PubMed ID: 29193983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.